Last reviewed · How we verify

salvianolate injection — Competitive Intelligence Brief

salvianolate injection (salvianolate injection) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / antiplatelet agent. Area: Cardiovascular / Cerebrovascular.

marketed Herbal extract / antiplatelet agent Cardiovascular / Cerebrovascular Small molecule Live · refreshed every 30 min

Target snapshot

salvianolate injection (salvianolate injection) — Green Valley Group of China. Salvianolate is a water-soluble extract from Salvia miltiorrhiza that improves microcirculation and reduces blood viscosity by inhibiting platelet aggregation and promoting fibrinolysis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
salvianolate injection TARGET salvianolate injection Green Valley Group of China marketed Herbal extract / antiplatelet agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / antiplatelet agent class)

  1. Green Valley Group of China · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). salvianolate injection — Competitive Intelligence Brief. https://druglandscape.com/ci/salvianolate-injection. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: